Genetic association study suggests involvement of sex-specific serotonin signaling in vasovagal syncope

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Associate Professor Brenda Gerull

Comprehensive Heart Failure Center (CHFC), Wurzburg (Germany)

6 More presentations in this session

Presentation thumbnail

The effect of adaptive cardiac resynchronization therapy in reducing atrial fibrillation in heart failure patients: insights from multicenter observational experience

Professor G. Boriani (Modena, IT)

Presentation thumbnail

The significance of early new onset of paroxysmal atrial fibrillation during acute myocardial infarction

Doctor M. Axelrod (Tel-Aviv, IL)

Presentation thumbnail

C-reactive protein and the risk of atrial fibrillation: KOGES 12 years' follow-up study

Assistant Professor Y. Lee (Seoul, KR)

Abstract Slides

Presentation thumbnail

Electrocardiographic and pathologic changes in young sudden death victims affected with arrhythmogenic cardiomyopathy: a clinic-pathology study

Doctor M. De Gaspari (Padova, IT)

Abstract Slides Video

Presentation thumbnail

Evolution towards bradycardia-tachycardia syndrome in patients with atrial fibrillation or sinus node disease : a French nationwide cohort-study

Doctor A. Bisson (Tours, FR)

Abstract Slides Video

Access the full session

Session thumbnail

Cardiac arrhythmias - Clinical aspects

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

How to manage patients with bradycardic phenotype: pace or ablate or...?

Congress Session

A practical update on diagnosis and treatment of vasovagal syncope

Congress Presentation

Young patient with syncopes and seizures: Antiepileptic drugs, pacemaker or cardioneuroablation?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources